Ascopiave Bilan de santé
Santé financière contrôle des critères 2/6
Ascopiave possède un total de capitaux propres de €891.6M et une dette totale de €665.5M, ce qui porte son ratio d'endettement à 74.6%. Son actif total et son passif total sont €1.8B et de €923.6M. L'EBIT de Ascopiave est €97.8M ce qui fait que son ratio de couverture des intérêts 7.9. Elle dispose de liquidités et de placements à court terme de €19.5M.
Informations clés
74.64%
Ratio d'endettement
€665.52m
Dette
| Ratio de couverture des intérêts | 7.9x |
| Argent liquide | €19.55m |
| Fonds propres | €891.64m |
| Total du passif | €923.59m |
| Total des actifs | €1.82b |
Mises à jour récentes de la santé financière
Article d’analyse • Feb 13
Is Ascopiave (BIT:ASC) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Article d’analyse • Mar 08
Ascopiave (BIT:ASC) Takes On Some Risk With Its Use Of Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Article d’analyse • Sep 26
Here's Why Ascopiave (BIT:ASC) Has A Meaningful Debt Burden
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Recent updates
Article d’analyse • Aug 08
We Think You Can Look Beyond Ascopiave's (BIT:ASC) Lackluster Earnings
The most recent earnings report from Ascopiave S.p.A. ( BIT:ASC ) was disappointing for shareholders. Despite the soft...
Mise à jour du récit • Jun 17
ASC: Stable Assumptions And Steady Dividend Will Support Future Upside
Analysts have left their fair value estimate for Ascopiave unchanged at €3.80. They cite only minor tweaks to discount rate, revenue growth and profit margin assumptions that do not materially alter their overall price target view.Mise à jour du récit • Jun 03
ASC: 2026 Dividend Will Support Future Upside Despite Lower Fair Value Estimate
Analysts have trimmed their fair value estimate for Ascopiave from €4.00 to €3.80, reflecting slightly lower assumptions for revenue growth, profit margins and future P/E multiples, while keeping the discount rate broadly unchanged. What's in the News Ascopiave S.p.A. announced an annual dividend of €0.1600 per share, according to a key developments update.Mise à jour du récit • Apr 28
ASC: 2026 Dividend And Stable Assumptions Will Support Future Upside Potential
Analysts have adjusted their price target on Ascopiave to €4.00 from €4.00, with the change linked to updated assumptions for discount rate, profit margins and forward P/E, while keeping fair value and revenue growth expectations aligned with prior views. What's in the News Ascopiave S.p.A. announced an annual dividend of €0.1600 per share.Mise à jour du récit • Apr 13
ASC: 2026 Dividend And Stable Fair Value Will Support Upside Potential
Analysts have nudged their price target on Ascopiave higher to €4.00, reflecting updated assumptions around slightly stronger revenue growth, a marginally lower discount rate and a modest adjustment to future P/E and profit margin expectations. What's in the News Ascopiave S.p.A. announced an annual dividend of €0.1600 per share, with payment scheduled for May 6, 2026, an ex dividend date of May 4, 2026, and a record date of May 5, 2026 (Key Developments).Mise à jour du récit • Mar 29
ASC: Higher Assumed Revenue And 2026 Dividend Policy Will Support Upside Potential
Analysts have raised their price target for Ascopiave from €3.87 to €4.00, citing updated views on the company’s expected revenue growth, profit margin profile and future P/E assumptions. What's in the News Annual dividend of €0.1600 per share announced, with payment scheduled for May 6, 2026 (Key Developments) Ex dividend date set for May 4, 2026, the deadline for buyers to be eligible for the announced dividend (Key Developments) Record date set for May 5, 2026, determining which shareholders qualify to receive the €0.1600 dividend (Key Developments) Valuation Changes Fair Value: Updated from €3.87 to €4.00, representing a small uplift in the estimated value per share.Mise à jour du récit • Mar 15
ASC: Updated Profitability Assumptions And 2026 Board Agenda Will Support Balanced Outlook
Analysts have nudged their price target on Ascopiave higher from about €3.77 to roughly €3.87, citing updated assumptions that reflect a slightly lower discount rate, modestly different revenue growth expectations, a higher projected profit margin and a small adjustment to the future P/E multiple. What's in the News A board meeting is scheduled for March 5, 2026, to consider and approve the draft financial statements for the 2025 financial year.Mise à jour du récit • Mar 01
ASC: 2026 Board Schedule And Stable Assumptions Will Support Balanced Outlook
Analysts have maintained their €3.77 price target for Ascopiave, citing largely stable assumptions around the discount rate, revenue growth, profit margin, and future P/E ratio in support of this view. What's in the News Board meeting scheduled for March 5, 2026, to consider and approve Ascopiave S.p.A.'s draft financial statements and consolidated financial statements for the 2025 financial year (Key Developments).Mise à jour du récit • Feb 15
ASC: 2026 Board Calendar And Assumption Shifts Will Frame Balanced Outlook
Analysts have raised their price target for Ascopiave to €3.77 from €3.77, citing updated assumptions that include a lower discount rate, slightly higher revenue growth, a firmer profit margin and a reduced future P/E multiple. What's in the News Board meeting scheduled for March 5, 2026, to consider and approve the draft financial statements and consolidated financial statements for the 2025 financial year (Key Developments).Article d’analyse • Feb 13
Is Ascopiave (BIT:ASC) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Mise à jour du récit • Feb 01
ASC: Upcoming 2026 Board Calendar Will Support Bullish Long-Term Outlook
Analysts have trimmed their price target on Ascopiave to €3.77. This reflects updated assumptions around discount rate, revenue growth, profit margin and future P/E, which leave their fair value view broadly unchanged.Mise à jour du récit • Jan 18
ASC: Fairly Valued Outlook Will Rely On Upcoming 2026 Board Decisions
Analysts have lifted their price target on Ascopiave to €3.77 from €3.45, reflecting updated views on its fair value, discount rate, revenue growth and profit margin, along with an adjusted future P/E assumption. What's in the News A board meeting is scheduled on Mar 05, 2026 to consider and approve the draft financial statements and consolidated financial statements for the 2025 financial year (Key Developments).Article d’analyse • Apr 17
Ascopiave S.p.A.'s (BIT:ASC) Popularity With Investors Is Under Threat From Overpricing
Ascopiave S.p.A.'s ( BIT:ASC ) price-to-earnings (or "P/E") ratio of 19.5x might make it look like a sell right now...
Nouveau récit • Mar 09
Wind Farm Projects And EstEnergy Stake Sale Will Improve Future Prospects
Strategic restructuring and simplification may enhance operational efficiencies and net margins through mergers and acquisitions, particularly in renewable energy and gas distribution.Article d’analyse • Feb 16
News Flash: Analysts Just Made A Notable Upgrade To Their Ascopiave S.p.A. (BIT:ASC) Forecasts
Ascopiave S.p.A. ( BIT:ASC ) shareholders will have a reason to smile today, with the analysts making substantial...Article d’analyse • Nov 17
Solid Earnings Reflect Ascopiave's (BIT:ASC) Strength As A Business
The subdued stock price reaction suggests that Ascopiave S.p.A.'s ( BIT:ASC ) strong earnings didn't offer any...Article d’analyse • Aug 02
€3.05: That's What Analysts Think Ascopiave S.p.A. (BIT:ASC) Is Worth After Its Latest Results
It's been a good week for Ascopiave S.p.A. ( BIT:ASC ) shareholders, because the company has just released its latest...Article d’analyse • Apr 25
Ascopiave's (BIT:ASC) Upcoming Dividend Will Be Larger Than Last Year's
Ascopiave S.p.A. ( BIT:ASC ) will increase its dividend from last year's comparable payment on the 8th of May to €0.14...Article d’analyse • Apr 07
Ascopiave's (BIT:ASC) Earnings Offer More Than Meets The Eye
Ascopiave S.p.A.'s ( BIT:ASC ) solid earnings announcement recently didn't do much to the stock price. We did some...Article d’analyse • Mar 13
Ascopiave's (BIT:ASC) Shareholders Will Receive A Bigger Dividend Than Last Year
Ascopiave S.p.A. ( BIT:ASC ) will increase its dividend from last year's comparable payment on the 8th of May to €0.14...Article d’analyse • Mar 08
Ascopiave (BIT:ASC) Takes On Some Risk With Its Use Of Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Article d’analyse • Mar 11
Ascopiave (BIT:ASC) Is Paying Out Less In Dividends Than Last Year
Ascopiave S.p.A. ( BIT:ASC ) has announced that on 4th of May, it will be paying a dividend of€0.13, which a reduction...Article d’analyse • Oct 20
Ascopiave S.p.A.'s (BIT:ASC) Intrinsic Value Is Potentially 50% Above Its Share Price
How far off is Ascopiave S.p.A. ( BIT:ASC ) from its intrinsic value? Using the most recent financial data, we'll take...Article d’analyse • Sep 26
Here's Why Ascopiave (BIT:ASC) Has A Meaningful Debt Burden
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Article d’analyse • Aug 12
Need To Know: The Consensus Just Cut Its Ascopiave S.p.A. (BIT:ASC) Estimates For 2022
Market forces rained on the parade of Ascopiave S.p.A. ( BIT:ASC ) shareholders today, when the analysts downgraded...Article d’analyse • Jun 14
Investors Could Be Concerned With Ascopiave's (BIT:ASC) Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...Article d’analyse • Mar 05
What Does Ascopiave S.p.A.'s (BIT:ASC) Share Price Indicate?
Ascopiave S.p.A. ( BIT:ASC ), might not be a large cap stock, but it saw significant share price movement during recent...Analyse de la situation financière
Passif à court terme: Les actifs à court terme de ASC ( €138.1M ) ne couvrent pas ses passifs à court terme ( €290.6M ).
Passif à long terme: Les actifs à court terme de ASC ( €138.1M ) ne couvrent pas ses passifs à long terme ( €633.0M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de ASC ( 72.4% ) est considéré comme élevé.
Réduire la dette: Le ratio d'endettement de ASC est passé de 40% à 74.6% au cours des 5 dernières années.
Couverture de la dette: La dette de ASC est bien couverte par le flux de trésorerie opérationnel ( 20.1% ).
Couverture des intérêts: Les paiements d'intérêts de ASC sur sa dette sont bien couverts par l'EBIT ( 7.9 x couverture).
Bilan
Découvrir des entreprises saines
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/09/13 19:56 |
| Cours de l'action en fin de journée | 2026/09/11 00:00 |
| Les revenus | 2026/06/30 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l' qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Ascopiave S.p.A. est couverte par 4 analystes. 3 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Luigi De Bellis | Equita SIM S.p.A. |
| Roberto Letizia | Equita SIM S.p.A. |
| Alberto Francese | Intesa Sanpaolo Equity Research |